CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria
PLoS Pathog
.
2021 Jul 8;17(7):e1009672.
doi: 10.1371/journal.ppat.1009672.
eCollection 2021 Jul.
Authors
Dennise Palacios Araya
1
,
Kelli L Palmer
1
,
Breck A Duerkop
2
Affiliations
1
Department of Biological Sciences, University of Texas at Dallas, Richardson, Texas, United States of America.
2
Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
PMID:
34237097
PMCID:
PMC8266055
DOI:
10.1371/journal.ppat.1009672
No abstract available
Publication types
Research Support, N.I.H., Extramural
Review
MeSH terms
Anti-Infective Agents / pharmacology*
CRISPR-Cas Systems*
Drug Resistance, Microbial*
Humans
Substances
Anti-Infective Agents
Grants and funding
R01 AI116610/AI/NIAID NIH HHS/United States
R01 AI141479/AI/NIAID NIH HHS/United States